ALBME

Volume 34 Number 3 | 2019

  • 2020 license and registration renewals
  • Notice - Licensee Portal
  • Welcome to new employees
  • ALBME social media guidelines
  • Starting Nov. 18 Gabapentin will be a Schedule V drug
  • Administrative rule changes
  • Public actions of the Board and Commission

Read Now